MUC5AC and cancer: On our TMA, 476 of 599 (79.5%) arrayed cancers were analyzable for MUC5AC IHC.Reasons for non-informative cases (n = 123, 20.5%) includedlack of tissue samples or absence of unequivocal cancer tissue in the TMAspot.